Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients

Table 5

Candidate drug compounds for COVID-19 and COPD.

Name of drug	DrugBank number	Chemical formula	value	Genes
Artesunate CTD 00001840	DB09274	C19H28O8	0.011	RPS12
Dexverapamil MCF7 UP	DB14063	C27H38N2O4	0.020	PKLR
STOCK1N-35696 PC3 DOWN	DB00625	C14H9ClF3NO2	0.018	RPL18A
hydralazine CTD 00006108	DB01275	C8H8N4	0.020	PL18A/RPS12
Gabexate PC3 UP	DB12831	C16H23N3O4	0.020	PKLR
Disodium selenite CTD 00007229	DB11127	Na2O3Se	0.003	RPS16/RPL18A/RPLP0/RPL8
FERRIC AMMONIUM CITRATE CTD 00000709	DB09501	C6H11FeNO7	0.009	MRPS9